IGF2BP2 mRNA expression was decreased in adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), and kidney renal cell carcinoma (KIRC) compared to their respective normal tissue controls, with log fold changes between tumor and normal tissue measuring −2.66 (ACC), −1.78 (BRCA), and −1.95 (KIRC), respectively (Figure 5B). Here, IGF2BP2 is linked to adrenal cortex carcinoma.